Request for Covid-19 Impact Assessment of this Report
The United States Neprilysin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Neprilysin market, reaching US$ million by the year 2028. As for the Europe Neprilysin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Neprilysin players cover Bioprojet SCR, Novartis AG, Pharmaleads SA, and Theravance Biopharma Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Neprilysin market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
TD-0714
STR-324
PL-265
LHW-090
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Acute Heart Failure
Cancer Pain
Hypertension
Alzheimer's Disease
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bioprojet SCR
Novartis AG
Pharmaleads SA
Theravance Biopharma Inc
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neprilysin Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Neprilysin by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Neprilysin by Country/Region, 2017, 2022 & 2028
2.2 Neprilysin Segment by Type
2.2.1 TD-0714
2.2.2 STR-324
2.2.3 PL-265
2.2.4 LHW-090
2.2.5 Others
2.3 Neprilysin Sales by Type
2.3.1 Global Neprilysin Sales Market Share by Type (2017-2022)
2.3.2 Global Neprilysin Revenue and Market Share by Type (2017-2022)
2.3.3 Global Neprilysin Sale Price by Type (2017-2022)
2.4 Neprilysin Segment by Application
2.4.1 Acute Heart Failure
2.4.2 Cancer Pain
2.4.3 Hypertension
2.4.4 Alzheimer's Disease
2.4.5 Others
2.5 Neprilysin Sales by Application
2.5.1 Global Neprilysin Sale Market Share by Application (2017-2022)
2.5.2 Global Neprilysin Revenue and Market Share by Application (2017-2022)
2.5.3 Global Neprilysin Sale Price by Application (2017-2022)
3 Global Neprilysin by Company
3.1 Global Neprilysin Breakdown Data by Company
3.1.1 Global Neprilysin Annual Sales by Company (2020-2022)
3.1.2 Global Neprilysin Sales Market Share by Company (2020-2022)
3.2 Global Neprilysin Annual Revenue by Company (2020-2022)
3.2.1 Global Neprilysin Revenue by Company (2020-2022)
3.2.2 Global Neprilysin Revenue Market Share by Company (2020-2022)
3.3 Global Neprilysin Sale Price by Company
3.4 Key Manufacturers Neprilysin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neprilysin Product Location Distribution
3.4.2 Players Neprilysin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Neprilysin by Geographic Region
4.1 World Historic Neprilysin Market Size by Geographic Region (2017-2022)
4.1.1 Global Neprilysin Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Neprilysin Annual Revenue by Geographic Region
4.2 World Historic Neprilysin Market Size by Country/Region (2017-2022)
4.2.1 Global Neprilysin Annual Sales by Country/Region (2017-2022)
4.2.2 Global Neprilysin Annual Revenue by Country/Region
4.3 Americas Neprilysin Sales Growth
4.4 APAC Neprilysin Sales Growth
4.5 Europe Neprilysin Sales Growth
4.6 Middle East & Africa Neprilysin Sales Growth
5 Americas
5.1 Americas Neprilysin Sales by Country
5.1.1 Americas Neprilysin Sales by Country (2017-2022)
5.1.2 Americas Neprilysin Revenue by Country (2017-2022)
5.2 Americas Neprilysin Sales by Type
5.3 Americas Neprilysin Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neprilysin Sales by Region
6.1.1 APAC Neprilysin Sales by Region (2017-2022)
6.1.2 APAC Neprilysin Revenue by Region (2017-2022)
6.2 APAC Neprilysin Sales by Type
6.3 APAC Neprilysin Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Neprilysin by Country
7.1.1 Europe Neprilysin Sales by Country (2017-2022)
7.1.2 Europe Neprilysin Revenue by Country (2017-2022)
7.2 Europe Neprilysin Sales by Type
7.3 Europe Neprilysin Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Neprilysin by Country
8.1.1 Middle East & Africa Neprilysin Sales by Country (2017-2022)
8.1.2 Middle East & Africa Neprilysin Revenue by Country (2017-2022)
8.2 Middle East & Africa Neprilysin Sales by Type
8.3 Middle East & Africa Neprilysin Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neprilysin
10.3 Manufacturing Process Analysis of Neprilysin
10.4 Industry Chain Structure of Neprilysin
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neprilysin Distributors
11.3 Neprilysin Customer
12 World Forecast Review for Neprilysin by Geographic Region
12.1 Global Neprilysin Market Size Forecast by Region
12.1.1 Global Neprilysin Forecast by Region (2023-2028)
12.1.2 Global Neprilysin Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Neprilysin Forecast by Type
12.7 Global Neprilysin Forecast by Application
13 Key Players Analysis
13.1 Bioprojet SCR
13.1.1 Bioprojet SCR Company Information
13.1.2 Bioprojet SCR Neprilysin Product Offered
13.1.3 Bioprojet SCR Neprilysin Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bioprojet SCR Main Business Overview
13.1.5 Bioprojet SCR Latest Developments
13.2 Novartis AG
13.2.1 Novartis AG Company Information
13.2.2 Novartis AG Neprilysin Product Offered
13.2.3 Novartis AG Neprilysin Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Novartis AG Main Business Overview
13.2.5 Novartis AG Latest Developments
13.3 Pharmaleads SA
13.3.1 Pharmaleads SA Company Information
13.3.2 Pharmaleads SA Neprilysin Product Offered
13.3.3 Pharmaleads SA Neprilysin Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Pharmaleads SA Main Business Overview
13.3.5 Pharmaleads SA Latest Developments
13.4 Theravance Biopharma Inc
13.4.1 Theravance Biopharma Inc Company Information
13.4.2 Theravance Biopharma Inc Neprilysin Product Offered
13.4.3 Theravance Biopharma Inc Neprilysin Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Theravance Biopharma Inc Main Business Overview
13.4.5 Theravance Biopharma Inc Latest Developments
14 Research Findings and Conclusion
Table 1. Neprilysin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Neprilysin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of TD-0714
Table 4. Major Players of STR-324
Table 5. Major Players of PL-265
Table 6. Major Players of LHW-090
Table 7. Major Players of Others
Table 8. Global Neprilysin Sales by Type (2017-2022) & (K Pcs)
Table 9. Global Neprilysin Sales Market Share by Type (2017-2022)
Table 10. Global Neprilysin Revenue by Type (2017-2022) & ($ million)
Table 11. Global Neprilysin Revenue Market Share by Type (2017-2022)
Table 12. Global Neprilysin Sale Price by Type (2017-2022) & (USD/Pcs)
Table 13. Global Neprilysin Sales by Application (2017-2022) & (K Pcs)
Table 14. Global Neprilysin Sales Market Share by Application (2017-2022)
Table 15. Global Neprilysin Revenue by Application (2017-2022)
Table 16. Global Neprilysin Revenue Market Share by Application (2017-2022)
Table 17. Global Neprilysin Sale Price by Application (2017-2022) & (USD/Pcs)
Table 18. Global Neprilysin Sales by Company (2020-2022) & (K Pcs)
Table 19. Global Neprilysin Sales Market Share by Company (2020-2022)
Table 20. Global Neprilysin Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Neprilysin Revenue Market Share by Company (2020-2022)
Table 22. Global Neprilysin Sale Price by Company (2020-2022) & (USD/Pcs)
Table 23. Key Manufacturers Neprilysin Producing Area Distribution and Sales Area
Table 24. Players Neprilysin Products Offered
Table 25. Neprilysin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Neprilysin Sales by Geographic Region (2017-2022) & (K Pcs)
Table 29. Global Neprilysin Sales Market Share Geographic Region (2017-2022)
Table 30. Global Neprilysin Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Neprilysin Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Neprilysin Sales by Country/Region (2017-2022) & (K Pcs)
Table 33. Global Neprilysin Sales Market Share by Country/Region (2017-2022)
Table 34. Global Neprilysin Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Neprilysin Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Neprilysin Sales by Country (2017-2022) & (K Pcs)
Table 37. Americas Neprilysin Sales Market Share by Country (2017-2022)
Table 38. Americas Neprilysin Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Neprilysin Revenue Market Share by Country (2017-2022)
Table 40. Americas Neprilysin Sales by Type (2017-2022) & (K Pcs)
Table 41. Americas Neprilysin Sales Market Share by Type (2017-2022)
Table 42. Americas Neprilysin Sales by Application (2017-2022) & (K Pcs)
Table 43. Americas Neprilysin Sales Market Share by Application (2017-2022)
Table 44. APAC Neprilysin Sales by Region (2017-2022) & (K Pcs)
Table 45. APAC Neprilysin Sales Market Share by Region (2017-2022)
Table 46. APAC Neprilysin Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Neprilysin Revenue Market Share by Region (2017-2022)
Table 48. APAC Neprilysin Sales by Type (2017-2022) & (K Pcs)
Table 49. APAC Neprilysin Sales Market Share by Type (2017-2022)
Table 50. APAC Neprilysin Sales by Application (2017-2022) & (K Pcs)
Table 51. APAC Neprilysin Sales Market Share by Application (2017-2022)
Table 52. Europe Neprilysin Sales by Country (2017-2022) & (K Pcs)
Table 53. Europe Neprilysin Sales Market Share by Country (2017-2022)
Table 54. Europe Neprilysin Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Neprilysin Revenue Market Share by Country (2017-2022)
Table 56. Europe Neprilysin Sales by Type (2017-2022) & (K Pcs)
Table 57. Europe Neprilysin Sales Market Share by Type (2017-2022)
Table 58. Europe Neprilysin Sales by Application (2017-2022) & (K Pcs)
Table 59. Europe Neprilysin Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Neprilysin Sales by Country (2017-2022) & (K Pcs)
Table 61. Middle East & Africa Neprilysin Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Neprilysin Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Neprilysin Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Neprilysin Sales by Type (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Neprilysin Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Neprilysin Sales by Application (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Neprilysin Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Neprilysin
Table 69. Key Market Challenges & Risks of Neprilysin
Table 70. Key Industry Trends of Neprilysin
Table 71. Neprilysin Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Neprilysin Distributors List
Table 74. Neprilysin Customer List
Table 75. Global Neprilysin Sales Forecast by Region (2023-2028) & (K Pcs)
Table 76. Global Neprilysin Sales Market Forecast by Region
Table 77. Global Neprilysin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Neprilysin Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Neprilysin Sales Forecast by Country (2023-2028) & (K Pcs)
Table 80. Americas Neprilysin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Neprilysin Sales Forecast by Region (2023-2028) & (K Pcs)
Table 82. APAC Neprilysin Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Neprilysin Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Europe Neprilysin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Neprilysin Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Middle East & Africa Neprilysin Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Neprilysin Sales Forecast by Type (2023-2028) & (K Pcs)
Table 88. Global Neprilysin Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Neprilysin Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Neprilysin Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Neprilysin Sales Forecast by Application (2023-2028) & (K Pcs)
Table 92. Global Neprilysin Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Neprilysin Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Neprilysin Revenue Market Share Forecast by Application (2023-2028)
Table 95. Bioprojet SCR Basic Information, Neprilysin Manufacturing Base, Sales Area and Its Competitors
Table 96. Bioprojet SCR Neprilysin Product Offered
Table 97. Bioprojet SCR Neprilysin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 98. Bioprojet SCR Main Business
Table 99. Bioprojet SCR Latest Developments
Table 100. Novartis AG Basic Information, Neprilysin Manufacturing Base, Sales Area and Its Competitors
Table 101. Novartis AG Neprilysin Product Offered
Table 102. Novartis AG Neprilysin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 103. Novartis AG Main Business
Table 104. Novartis AG Latest Developments
Table 105. Pharmaleads SA Basic Information, Neprilysin Manufacturing Base, Sales Area and Its Competitors
Table 106. Pharmaleads SA Neprilysin Product Offered
Table 107. Pharmaleads SA Neprilysin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 108. Pharmaleads SA Main Business
Table 109. Pharmaleads SA Latest Developments
Table 110. Theravance Biopharma Inc Basic Information, Neprilysin Manufacturing Base, Sales Area and Its Competitors
Table 111. Theravance Biopharma Inc Neprilysin Product Offered
Table 112. Theravance Biopharma Inc Neprilysin Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 113. Theravance Biopharma Inc Main Business
Table 114. Theravance Biopharma Inc Latest Developments
List of Figures
Figure 1. Picture of Neprilysin
Figure 2. Neprilysin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neprilysin Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Neprilysin Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Neprilysin Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of TD-0714
Figure 10. Product Picture of STR-324
Figure 11. Product Picture of PL-265
Figure 12. Product Picture of LHW-090
Figure 13. Product Picture of Others
Figure 14. Global Neprilysin Sales Market Share by Type in 2021
Figure 15. Global Neprilysin Revenue Market Share by Type (2017-2022)
Figure 16. Neprilysin Consumed in Acute Heart Failure
Figure 17. Global Neprilysin Market: Acute Heart Failure (2017-2022) & (K Pcs)
Figure 18. Neprilysin Consumed in Cancer Pain
Figure 19. Global Neprilysin Market: Cancer Pain (2017-2022) & (K Pcs)
Figure 20. Neprilysin Consumed in Hypertension
Figure 21. Global Neprilysin Market: Hypertension (2017-2022) & (K Pcs)
Figure 22. Neprilysin Consumed in Alzheimer's Disease
Figure 23. Global Neprilysin Market: Alzheimer's Disease (2017-2022) & (K Pcs)
Figure 24. Neprilysin Consumed in Others
Figure 25. Global Neprilysin Market: Others (2017-2022) & (K Pcs)
Figure 26. Global Neprilysin Sales Market Share by Application (2017-2022)
Figure 27. Global Neprilysin Revenue Market Share by Application in 2021
Figure 28. Neprilysin Revenue Market by Company in 2021 ($ Million)
Figure 29. Global Neprilysin Revenue Market Share by Company in 2021
Figure 30. Global Neprilysin Sales Market Share by Geographic Region (2017-2022)
Figure 31. Global Neprilysin Revenue Market Share by Geographic Region in 2021
Figure 32. Global Neprilysin Sales Market Share by Region (2017-2022)
Figure 33. Global Neprilysin Revenue Market Share by Country/Region in 2021
Figure 34. Americas Neprilysin Sales 2017-2022 (K Pcs)
Figure 35. Americas Neprilysin Revenue 2017-2022 ($ Millions)
Figure 36. APAC Neprilysin Sales 2017-2022 (K Pcs)
Figure 37. APAC Neprilysin Revenue 2017-2022 ($ Millions)
Figure 38. Europe Neprilysin Sales 2017-2022 (K Pcs)
Figure 39. Europe Neprilysin Revenue 2017-2022 ($ Millions)
Figure 40. Middle East & Africa Neprilysin Sales 2017-2022 (K Pcs)
Figure 41. Middle East & Africa Neprilysin Revenue 2017-2022 ($ Millions)
Figure 42. Americas Neprilysin Sales Market Share by Country in 2021
Figure 43. Americas Neprilysin Revenue Market Share by Country in 2021
Figure 44. United States Neprilysin Revenue Growth 2017-2022 ($ Millions)
Figure 45. Canada Neprilysin Revenue Growth 2017-2022 ($ Millions)
Figure 46. Mexico Neprilysin Revenue Growth 2017-2022 ($ Millions)
Figure 47. Brazil Neprilysin Revenue Growth 2017-2022 ($ Millions)
Figure 48. APAC Neprilysin Sales Market Share by Region in 2021
Figure 49. APAC Neprilysin Revenue Market Share by Regions in 2021
Figure 50. China Neprilysin Revenue Growth 2017-2022 ($ Millions)
Figure 51. Japan Neprilysin Revenue Growth 2017-2022 ($ Millions)
Figure 52. South Korea Neprilysin Revenue Growth 2017-2022 ($ Millions)
Figure 53. Southeast Asia Neprilysin Revenue Growth 2017-2022 ($ Millions)
Figure 54. India Neprilysin Revenue Growth 2017-2022 ($ Millions)
Figure 55. Australia Neprilysin Revenue Growth 2017-2022 ($ Millions)
Figure 56. Europe Neprilysin Sales Market Share by Country in 2021
Figure 57. Europe Neprilysin Revenue Market Share by Country in 2021
Figure 58. Germany Neprilysin Revenue Growth 2017-2022 ($ Millions)
Figure 59. France Neprilysin Revenue Growth 2017-2022 ($ Millions)
Figure 60. UK Neprilysin Revenue Growth 2017-2022 ($ Millions)
Figure 61. Italy Neprilysin Revenue Growth 2017-2022 ($ Millions)
Figure 62. Russia Neprilysin Revenue Growth 2017-2022 ($ Millions)
Figure 63. Middle East & Africa Neprilysin Sales Market Share by Country in 2021
Figure 64. Middle East & Africa Neprilysin Revenue Market Share by Country in 2021
Figure 65. Egypt Neprilysin Revenue Growth 2017-2022 ($ Millions)
Figure 66. South Africa Neprilysin Revenue Growth 2017-2022 ($ Millions)
Figure 67. Israel Neprilysin Revenue Growth 2017-2022 ($ Millions)
Figure 68. Turkey Neprilysin Revenue Growth 2017-2022 ($ Millions)
Figure 69. GCC Country Neprilysin Revenue Growth 2017-2022 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Neprilysin in 2021
Figure 71. Manufacturing Process Analysis of Neprilysin
Figure 72. Industry Chain Structure of Neprilysin
Figure 73. Channels of Distribution
Figure 74. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...